banner about

Prof. Dr. Frank W. Falkenberg

FrankScientific Director

Received a MSc in Biochemistry at the J.W. Goethe Universität in Frankfurt/Main and his Doctorate in Biochemistry at the Department of Biochemistry (Faculty of Chemistry) of the Ruhr-Universität Bochum. From 1971 – 1973 he was Post-Doctoral Fellow at the Department of Chemical Immunology of the Weizman Institute of Science in Rehovot, Israel. In 1981, after Habilitation, he became Privat-Dozent at the Department of Medical Microbiology, Medical Faculty of the Ruhr-Universität Bochum. In 1986 he became Professor of Immunology in the Medical Faculty of the Ruhr-Universität Bochum, and his scientific work focused on immunogenetics, cellular immunology, tumor immunology, renal toxicity, high-density cell culture and bioreactor technology. During the last 15 years he worked on the development of the CyTuVax tumor vaccine concept. Falkenberg holds German and international patents in the fields of bioreactor technology, tumor immunology and nephrotoxicity testing. In 2001 he founded CIRES cell + immune research services GmbH, a biotech contract research company in Dortmund. In 2011 he co-founded CyTuVax.




Latest news

showCyTuVax is currently testing its vaccine technology in a clinical Phase 2 study of a vaccine for hepatitis B non-responders

Where we are

About us

CyTuVax B.V.
Oxfordlaan 55
6229 EV Maastricht
The Netherlands

This email address is being protected from spambots. You need JavaScript enabled to view it.